These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38349159)

  • 21. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Effect of Cinnarizine on Promastigotes and Amastigotes forms of Leishmania major.
    Sarouey LA; Rahimi-Moghaddam P; Tabatabaie F; Khanaliha K
    Infect Disord Drug Targets; 2020; 20(4):550-555. PubMed ID: 30421686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone.
    Mahmoudvand H; Tavakoli R; Sharififar F; Minaie K; Ezatpour B; Jahanbakhsh S; Sharifi I
    Pharm Biol; 2015 Jul; 53(7):1052-7. PubMed ID: 25471014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazolidine derivatives: In vitro toxicity assessment against promastigote and amastigote forms of Leishmania infantum and ultrastructural study.
    Gouveia ALA; Santos FAB; Alves LC; Cruz-Filho IJ; Silva PR; Jacob ITT; Soares JCS; Santos DKDN; Souza TRCL; Oliveira JF; Lima MDCA
    Exp Parasitol; 2022; 236-237():108253. PubMed ID: 35381223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
    Costa RR; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Mendonça DVC; Freitas CS; Lage DP; Martins VT; Antinarelli LMR; Machado AS; Bandeira RS; Ludolf F; Santos TTO; Brito RCF; Humbert MV; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Coimbra ES; Coelho EAF
    Med Microbiol Immunol; 2021 Jun; 210(2-3):133-147. PubMed ID: 33870453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
    Sousa JKT; Antinarelli LMR; Mendonça DVC; Lage DP; Tavares GSV; Dias DS; Ribeiro PAF; Ludolf F; Coelho VTS; Oliveira-da-Silva JA; Perin L; Oliveira BA; Alvarenga DF; Chávez-Fumagalli MA; Brandão GC; Nobre V; Pereira GR; Coimbra ES; Coelho EAF
    Parasitol Int; 2019 Dec; 73():101966. PubMed ID: 31362122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
    Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
    Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum.
    Di Giorgio C; Delmas F; Ollivier E; Elias R; Balansard G; Timon-David P
    Exp Parasitol; 2004; 106(3-4):67-74. PubMed ID: 15172213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
    Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major.
    Shokri A; Emami S; Fakhar M; Teshnizi SH; Keighobadi M
    Acta Trop; 2017 Mar; 167():73-78. PubMed ID: 28017860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents.
    Ansari SB; Kamboj S; Ramalingam K; Meena R; Lal J; Kant R; Shukla SK; Goyal N; Reddy DN
    Bioorg Chem; 2023 Aug; 137():106593. PubMed ID: 37186964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New diarylsulfonamide inhibitors of Leishmania infantum amastigotes.
    González M; Alcolea PJ; Álvarez R; Medarde M; Larraga V; Peláez R
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():45-64. PubMed ID: 34015753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological Evaluation and Mechanistic Studies of Quinolin-(1
    Gomes-Alves AG; Duarte M; Cruz T; Castro H; Lopes F; Moreira R; Ressurreição AS; Tomás AM
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0151320. PubMed ID: 33903112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents.
    Porcino GN; Antinarelli LMR; Maia ACRG; Faria-Pinto P; Taunay-Rodrigues A; Zech Coelho PM; Nelson DL; Penido MLO; Coimbra ES; Vasconcelos EG
    J Pharm Pharmacol; 2019 Dec; 71(12):1784-1791. PubMed ID: 31579947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-
    Cruz MGFdML; Santi AMM; Morais-Teixeira Ed; Caldeira ASP; Siqueira EPd; Oliveira E; Alves TMdA; Murta SMF
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0050923. PubMed ID: 38063403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and anti-leishmanial evaluation of 1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline derivatives against Leishmania infantum.
    Ashok P; Chander S; Tejería A; García-Calvo L; Balaña-Fouce R; Murugesan S
    Eur J Med Chem; 2016 Nov; 123():814-821. PubMed ID: 27541264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.